Navigation Links
New Research Reveals Need for Doctors to Know About Medical Tattoos
Date:4/21/2009

HOUSTON, April 21 /PRNewswire-USNewswire/ -- More people are turning to a new trend to let others know about their medical condition - tattooing. A case report will be presented Friday, May 15, at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress shedding light on this new phenomenon, while urging discussion from the medical community.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

One of the most obvious benefits of medical tattooing is for identification purposes in an emergency situation, especially for patients with diabetes, when a patient may be incapacitated - particularly in the case of hypoglycemic coma. However, it also poses some health concerns - ones that the study's primary author, Saleh Aldasouqi, MD, FACE, feels the medical community may need to weigh in on.

"Like it or not, tattooing for purposes of medical alerts is a phenomenon that is now occurring," Dr. Aldasouqi said. "It's imperative that the medical community take note and that, perhaps, appropriate regulation of the practice be proposed, especially for patients with diabetes."

Once that happens, Dr. Aldasouqi hopes that patients and their doctors can sit down, analyze the risks and benefits, and make an informed decision together.

Also at the 2009 AACE 18th Annual Meeting & Clinical Congress, diabetes experts will analyze the NICE-SUGAR study's impact on inpatient glycemic control. Other topics of interest include a look at the wide ranging impact of vitamin D in the human body, and clinical recommendations for the treatment of prediabetes - America's largest healthcare epidemic.

A short, one page bio and photo of Dr. Aldasouqi are available here.

Media Registration

Media Registration for the AACE 18th Annual Meeting & Clinical Congress is available free of charge to members of the working media online here. Additional press releases concerning the meeting are available online here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.

About the AACE Annual Meeting

The 18th Annual Meeting & Clinical Congress will be held in Houston, Texas, on May 13-17 at the George R. Brown Convention Center, Hilton Americas Houston. The AACE Annual Meeting & Clinical Congress is structured to provide relevant clinical information for the practicing endocrinologist. The programs will focus on information that allows endocrinologists to achieve the best solutions for the diagnosis and management of endocrine diseases. Pertinent scientific, clinical practice and patient management will be disseminated via general sessions, workshops, meet-the-experts and satellite symposia.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument
2. Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors
3. New Research Shows Healthy Choice Lives Up To Its Name
4. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
5. Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells
6. USC researchers develop new drug to target tumor cells and blood vessels
7. Medarex Announces Clinical Data for MDX-1401 in Hodgkins Lymphoma at Annual Meeting of the American Association for Cancer Research
8. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
9. LSUHSC research shows fish oil protects against diseases like Parkinsons
10. Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
11. Research Takes Aim at Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. ... that his parents and teachers had asked of him that he had neglected to do, ... defy the Almighty Creator. There were some who would have felt themselves to be special ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... custom smile makeovers without requiring a referral. Trimble Dental offers a ... treatment, cosmetic dentistry and dental implants. Whether patients have discolored, crooked or missing ...
(Date:3/27/2017)... ... 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope ... the key role this treatment plays in protecting oral health, along with the benefits ... those who need a root canal in White Plains, NY or their second location ...
(Date:3/27/2017)... ... 2017 , ... This is the second major release since ... 2014. It is the culmination of collaborative efforts by members of the OSEHRA ... Member Zato Health co-funded the ONC certification and provided key technical support throughout ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Medtec Europe ... more than 600 exhibitors from 70 countries the ... solutions that will advance the medical technology industry. ... the Messe Stuttgart, Stuttgart, Germany ... platform showcasing the key trends and insights across ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
(Date:3/27/2017)... VANCOUVER , March 27, 2017 /PRNewswire/ - INVICTUS ... OTC: IVITF; FRA: 8IS) Invictus MD is pleased to ... common shares for trading on the TSX Venture Exchange.  ... the TSXV follows a year of significant achievements for ... The successful test crops at AB Laboratories Inc. ("AB ...
Breaking Medicine Technology: